Cannara Biotech Inc.
LOVFF
$0.9125
$0.00610.67%
OTC PK
11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 7.32M | 4.91M | 4.01M | 2.31M | 1.94M |
Total Receivables | 9.23M | 9.66M | 8.67M | 8.45M | 7.28M |
Inventory | 29.79M | 29.70M | 27.45M | 27.04M | 27.08M |
Prepaid Expenses | 2.44M | 2.11M | 1.74M | 1.45M | 2.57M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 3.50M | 3.63M | 3.59M | 3.65M | -- |
Total Current Assets | 52.28M | 50.00M | 45.46M | 42.90M | 38.87M |
|
|||||
Total Current Assets | 52.28M | 50.00M | 45.46M | 42.90M | 38.87M |
Net Property, Plant & Equipment | 61.30M | 62.94M | 63.34M | 64.24M | 67.43M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.34M | 1.71M | 246.30K | 307.70K | 394.80K |
Total Assets | 114.92M | 114.65M | 109.04M | 107.44M | 106.70M |
|
|||||
Total Accounts Payable | 8.23M | 7.04M | 6.69M | 11.12M | 8.52M |
Total Accrued Expenses | 6.13M | 5.82M | 5.62M | 582.70K | 1.07M |
Short-term Debt | 4.82M | 4.64M | 4.59M | 4.79M | 4.05M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 6.57M | 2.41M | 2.37M | 27.49M | 2.37M |
Total Finance Division Other Current Liabilities | 303.60K | 99.90K | 357.70K | 291.20K | 384.50K |
Total Other Current Liabilities | 303.60K | 99.90K | 357.70K | 291.20K | 384.50K |
Total Current Liabilities | 26.06M | 20.01M | 19.63M | 44.27M | 16.40M |
|
|||||
Total Current Liabilities | 26.06M | 20.01M | 19.63M | 44.27M | 16.40M |
Long-Term Debt | 23.32M | 28.50M | 28.55M | 3.78M | 29.04M |
Short-term Debt | 4.82M | 4.64M | 4.59M | 4.79M | 4.05M |
Capital Leases | 235.00K | 273.10K | 321.60K | 374.00K | 383.30K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 653.80K | 700.30K | 612.80K | 558.30K | 565.40K |
Total Liabilities | 50.27M | 49.48M | 49.11M | 48.99M | 46.39M |
|
|||||
Common Stock & APIC | 72.21M | 74.73M | 73.65M | 73.74M | 73.06M |
Retained Earnings | -7.56M | -9.56M | -13.67M | -15.23M | -12.69M |
Treasury Stock & Other | -- | -- | -50.80K | -51.10K | -51.10K |
Total Common Equity | 64.65M | 65.18M | 59.93M | 58.46M | 60.31M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 64.65M | 65.18M | 59.93M | 58.46M | 60.31M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 64.65M | 65.18M | 59.93M | 58.46M | 60.31M |
|